Ying‐Huang Tsai

Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial

Martin Schüler, James Chih‐Hsin Yang, K. Park et al. · Annals of Oncology · 2015 · 132 citations · Full text

Medicine, Oncology, Pharmacology +13

Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study

Ming‐Szu Hung, I‐Chuan Chen, Chuan-Pin Lee et al. · PLoS ONE · 2017 · 83 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer

Ching‐Feng Wu, Jui‐Ying Fu, Chi‐Ju Yeh et al. · Medicine · 2015 · 64 citations · Full text

Medicine, Oncology, Surgery +16

Unilateral Vocal Fold Paralysis and Risk of Pneumonia: A Nationwide Population‐Based Cohort Study

Ming‐Shao Tsai, Yao‐Hsu Yang, Chia‐Yen Liu et al. · Otolaryngology · 2018 · 59 citations

Medicine, Health Sciences, Speech-language Pathology +16

Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers

Y. M. Dennis Lo, Chin‐Fu Hsiao, Yuh‐Shan Jou et al. · Lung Cancer · 2010 · 56 citations

Life Sciences, Genetics, Molecular Genetics +14